HTR1D inhibitor GR127935 suppresses proliferation and migration of gastric cancer via cell cycle arrest and repression of EMT
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA825544 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR18715968.fastq.gz | Fastqsanger.gz | |||
| SRR18715969.fastq.gz | Fastqsanger.gz | |||
| SRR18715970.fastq.gz | Fastqsanger.gz | |||
| SRR18715971.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 4 of 4 |
Similar Datasets
Project description:SAMD1, a CpG island-binding protein, plays a pivotal role in the repression of its target genes by influencing the activity of KDM1A. Despite its significant correlation with outcomes in various tumor types, SAMD1's role in cancer has remained largely unexplored. In this study, we focus on pancreatic ductal adenocarcinoma (PDAC) and reveal that SAMD1 is a repressor of genes associated with epithelial-mesenchymal transition (EMT). Upon depletion of SAMD1 in PDAC cells, we observed significantly increased migration rates. Furthermore, high SAMD1 expression in PDAC patients correlated with lower expression of EMT signature genes and better prognosis, further underscoring its suppressive role. In-depth analysis revealed that SAMD1 exerts its effects by binding to specific genomic targets, including CDH2, encoding N-Cadherin, which emerged as a driver of enhanced migration upon SAMD1 knockout. Our investigations further demonstrated reduced chromatin-binding activity of SAMD1 in PDAC cells, prompting a search for regulatory mechanisms. This led to the discovery of the FBXO11-containing E3 ubiquitin ligase complex as a novel interactor of SAMD1, critically influencing its chromatin binding genome-wide. High FBXO11 expression in PDAC is associated with poor prognosis and increased expression of EMT-related genes, implying an antagonistic relationship between SAMD1 and FBXO11. In summary, our findings provide new insights into the regulation of EMT-related genes in PDAC, shedding light on the intricate role of SAMD1 and its interplay with FBXO11 in this particular cancer type.
2024-07-12 | PXD044104 | Pride
Project description:The changes of gene expression of AGS and SGC7901 treated with GR127935(5 μM or 0 μM )
2022-04-16 | GSE200618 | GEO
Project description:Nuclear receptor coactivator 5 (NCOA5) is an AF2-independent coactivator that contains both transcriptional activation and repression domains. Previous studies have shown that NCOA5 plays an important role in the development of a variety of malignancies. However, the underlying mechanisms remain unclear. In our study, we successfully generated the NCOA5 knockout liver cancer cell lines by CRISPR/Cas9 -mediated genome editing and found that NCOA5 knockout inhibited the proliferation and migration of hepatocellular carcinoma (HCC) cells significantly, meanwhile led to a marked decrease in tumor microsphere formation. Furthermore, mechanistic analyses indicated that NCOA5 knockout can inhibit the EMT process. In this study, knocking out NCOA5 in hepatoma cells LM3 with CRISPR/Cas9 provides an important cellular model for studying role of NCOA5 in HCC. In conclusion , Oour study provides new insights and evidence that NOCA5 was significantly correlated with the progression of HCC and was particularly involved in EMT.
2019-05-21 | GSE111829 | GEO
Project description:MESH1 knockdown triggers proliferation arrest through TAZ repression
| PRJNA612863 | ENA
Project description:Purpose: To identify differntially expressed transcripts in TP-0903 treated embryos that impair cranila NC EMT and cell migration in zebrafish embryos Methods: zebrafish embryos treated at 13 hpf with 5-7uM TP-0903 and DMSO for 1-, 4- and 8-hrs at 28°C. 35 embryos were collected for each treatment. Results: TP-0903 increases expression of several retinoic acid target genes including genes from within the retinoid pathway Conclusions: TP-0903 causes a direct increase in RA signaling that impairs cranial NC EMT and cell migration in zebrafihs embryos mRNA profiles of zebrafish embryos treated with TP-0903 and DMSO were generated by RNA-Seq, in quadruplicates, using Illumina Hi Seq
2016-02-18 | E-GEOD-72322 | biostudies-arrayexpress
Project description:Despite advancements in cancer therapy, metastasis and chemoresistance remain critical challenges due to tumor heterogeneity and compensatory pathways. This study investigates the synergistic anti-tumor potential of Flos Sophorae Immaturus (FSI) and broccoli seed extract (BSE), two natural products aligned with the "medicinal food homology" paradigm. Using in vitro and in vivo models of lung and prostate cancers, we demonstrate that FSI-BSE (F/B extract) co-treatment exerts supra-additive effects by concurrently inducing G2/M cell cycle arrest and suppressing epithelial-mesenchymal transition (EMT). Mechanistically, with integrative LC-MS/MS, network pharmacology, molecular docking, transcriptomic profiling, and molecular experimental validation, this study revealed that F/B extract targets and disrupts the cell cycle regulators such as cyclin-dependent kinases (CDKs) and cell division cycle 25 (CDC25), as well as the EMT effectors (e.g., Matrix metalloproteinase, Snail, and E-cadherin). Additionally, F/B extract suppressed tumor growth without toxicity in xenograft mouse models, supported by unaltered organ histology and blood parameters. These findings demonstrate a polypharmacological strategy leveraging dietary botanicals to address cancer complexity. By bridging cell cycle arrest and EMT inhibition, F/B extract treatment offers a non-toxic adjuvant approach with translational potential, underscoring the therapeutic value of medicinal food homology in oncology.
2025-09-01 | GSE305654 | GEO
Project description:Purpose: To identify differntially expressed transcripts in TP-0903 treated embryos that impair cranila NC EMT and cell migration in zebrafish embryos Methods: zebrafish embryos treated at 13 hpf with 5-7uM TP-0903 and DMSO for 1-, 4- and 8-hrs at 28°C. 35 embryos were collected for each treatment. Results: TP-0903 increases expression of several retinoic acid target genes including genes from within the retinoid pathway Conclusions: TP-0903 causes a direct increase in RA signaling that impairs cranial NC EMT and cell migration in zebrafihs embryos
2016-02-18 | GSE72322 | GEO
Project description:Tumors and tumor surrounding tissues produce multiple growth factors that influence tumor cell behavior via different signal transduction pathways. Growth factors like transforming growth factor beta (TGFβ) and epidermal growth factor (EGF) were shown to induce proliferation, migration and invasion in different cell models. Both factors are frequently overexpressed in cancer and will often act in combination. Although both factors are being used as rational targets in clinical oncology, similarities and differences of their contributions to cancer cell migration and invasion are not fully understood. Here we compared the impact of TGFβ, EGF and the combination of both factors on A549 cells. Both factors stimulated A549 migration to a similar extent but with a different kinetic and the combination had an additive effect. While EGF-induced migration depended on activation of the mitogen-activated protein kinase (MAPK) pathway, this pathway was dispensable for TGFβ-induced migration despite a strong activation by TGFβ. Proteome analysis revealed an overlap in expression patterns of migration-related proteins and associated gene ontology (GO) terms by TGFβ and EGF but only TGFβ induced the expression of epithelial to mesenchymal transition (EMT)-related proteins like matrix metalloproteinase 2 (MMP2). EGF in contrast, made no major contribution to EMT marker expression on either the protein or the transcript level. In line with these expression patterns, EGF was unable to increase invasion of A549 cells on its own and failed to enhance TGFβ-induced invasion. Overall, these data suggest that TGFβ and EGF may partly compensate each other for stimulation of cell migration but abrogation of TGFβ signaling may be more suitable for antagonizing invasion.
2021-04-08 | PXD023024 | Pride
Project description:Meiotic maturation of vertebrate oocytes occurs in the near-absence of transcription. Thus, female fertility relies on timely translational activation of maternal transcripts stockpiled in full-grown prophase-I-arrested oocytes. However, how expression of these mRNAs is suppressed to maintain the long-lasting prophase-I arrest remains mysterious. Utilizing fast-acting TRIM-Away, we demonstrate that acute loss of the translation repressor 4E-T triggers spontaneous release from prophase-I arrest in mouse and frog oocytes. This is due to untimely expression of key meiotic drivers like c-Mos and cyclin-B1. Notably, mutant 4E-T associated with premature ovarian insufficiency fails to maintain the prophase-I arrest in Xenopus oocytes. We further show that 4E-T association with eIF4E and PATL2 is critical for target mRNA binding and repression. Thus, 4E-T is a central factor in translational repression of mRNAs stockpiled in full-grown oocytes for later activation and, therefore, essential to sustain the oocyte pool throughout the reproductive lifespan of female vertebrates.
2025-07-18 | PXD062261 | Pride
Project description:Cancer cells exploit the epithelial-to-mesenchymal transition (EMT) program toward metastasis. Cytoskeletal regulators are dually required in mesenchymal cells by promoting EMT-induced migration and sustaining the EMT program itself. In search for novel regulators of metastasis, we conducted an shRNA screen targeting a class of microtubule regulators, the plus-end tracking proteins (+TIPs). We show that the +TIP ACF7 is required for both the maintenance of EMT and to promote migration. We identified HectD1 as a potent E3 ubiquitin ligase mediating ACF7 degradation. Depletion of HectD1 robustly increases ACF7 protein levels and this is sufficient to enhance migration and EMT in cells, as well as facilitate metastasis in vivo. Ours results report the HectD1/ACF7 axis as a novel regulator of metastasis of breast cancer cells.
2018-01-03 | GSE100092 | GEO